Edition:
United States

Navidea Biopharmaceuticals Inc (NAVB.A)

NAVB.A on American Stock Exchange

0.49USD
23 Feb 2017
Change (% chg)

$0.03 (+7.45%)
Prev Close
$0.46
Open
$0.44
Day's High
$0.66
Day's Low
$0.43
Volume
197,035
Avg. Vol
90,479
52-wk High
$1.51
52-wk Low
$0.26

NAVB.A

Chart for NAVB.A

About

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease.... (more)
No analyst recommendations are available for NAVB.A.

Overall

Beta: -0.07
Market Cap(Mil.): $76.34
Shares Outstanding(Mil.): 155.76
Dividend: --
Yield (%): --

Financials

  NAVB.A Industry Sector
P/E (TTM): -- 44.59 29.71
EPS (TTM): -0.09 -- --
ROI: -- -3.18 12.94
ROE: -- 5.86 14.09

BRIEF-Court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

* On Feb 9, court entered interlocutory order declaring Navidea, Macrophage committed one or more events of default under loan agreement

Feb 16 2017

BRIEF-Navidea Biopharmaceuticals enters asset purchase agreement with Cardinal Health

* Press release - Navidea signs asset purchase agreement with Cardinal Health

Nov 23 2016

BRIEF-Navidea Biopharmaceuticals Q3 EPS $0.00

* Q3 revenue $8.5 million Source text for Eikon: Further company coverage:

Nov 03 2016

BRIEF-Navidea Biopharma says appoints Michael Goldberg, M.D. as CEO

* Says appoints Michael M. Goldberg, M.D. president and chief executive officer

Sep 26 2016

BRIEF-Navidea achieves $1 mln in Lymphoseek commercial milestones

* Navidea achieves $1 million in Lymphoseek commercial milestones

Sep 22 2016

BRIEF-Navidea enters into letter of intent with cardinal health for sale of Lymphoseek in North America

* Navidea Biopharmaceuticals enters into letter of intent with cardinal health for the sale of Lymphoseek in North America

Sep 06 2016

More From Around the Web

Competitors

  Price Chg
General Electric Company (GE.N) $30.19 +0.17
Bayer AG (BAYGn.DE) €104.25 -0.85
Bayer AG (BAYE.F) -- --
Eli Lilly and Co (LLY.N) $82.87 +0.32

Earnings vs. Estimates